Determination of free and total vincristine in human plasma after intravenous administration of vincristine sulfate liposome injection using ultra-high performance liquid chromatography tandem mass spectrometry

This publication has 19 references indexed in Scilit:

• Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome
  Journal of Chromatography B: Biomedical Sciences and Applications, 2001
• Vincristine revisited
  Critical Reviews in Oncology/Hematology, 1999
• Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer
  Cancer Chemotherapy and Pharmacology, 1998
• Comparative Study of Separation of Non-encapsulated Drug from Unilamellar Liposomes by Various Methods
  Journal of Pharmacy and Pharmacology, 1996
• Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models
  British Journal of Cancer, 1995
• Liposome encapsulated vincristine: preclinical toxicologic and pharmacologic comparison with free vincristine and empty liposomes in mice, rats and dogs
  Anti-Cancer Drugs, 1994
• Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma
  Analytical Biochemistry, 1990
• Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: Implications for pharmacokinetic studies
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1989
• Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts
  Biochemical Pharmacology, 1988
• Vinblastine and Griseofulvin Reversibly Disrupt the Living Mitotic Spindle
  Science, 1968